T1	Participants 87 109	Clostridium difficile.
T2	Participants 344 360	patients with C.
T3	Participants 361 397	difficile-associated diarrhea (CDAD)
T4	Participants 779 800	77 patients with CDAD
T5	Participants 1068 1087	patients with CDAD.
T6	Participants 1183 1204	individuals with CDAD
